(Q44961338)

English

Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial (English)

1 reference

Europe PubMed Central

7 December 2017

1 reference

based on heuristic

inferred from title

respiratory allergy

1 reference

based on heuristic

inferred from title

bronchial hyperresponsiveness

1 reference

based on heuristic

inferred from title

author name string

Pajno GB

1

1 reference

Europe PubMed Central

7 December 2017

Passalacqua G

2

1 reference

Europe PubMed Central

7 December 2017

Vita D

3

1 reference

Europe PubMed Central

7 December 2017

Caminiti L

4

1 reference

Europe PubMed Central

7 December 2017

Parmiani S

5

1 reference

Europe PubMed Central

7 December 2017

Barberio G

6

1 reference

Europe PubMed Central

7 December 2017

publication date

1 August 2004

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

59

1 reference

Europe PubMed Central

7 December 2017

8

1 reference

Europe PubMed Central

7 December 2017

883-887

1 reference

Europe PubMed Central

7 December 2017

Immunotherapy in asthma: an updated systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00578.X

21 January 2018

Noninjection routes for immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00578.X

21 January 2018

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00578.X

21 January 2018

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00578.X

21 January 2018

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00578.X

21 January 2018

Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00578.X

21 January 2018

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00578.X

21 January 2018

Identifiers

10.1111/J.1398-9995.2004.00578.X

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44961338&oldid=2059742950"